UroGen Pharma Ltd.

NasdaqGM:URGN Stock Report

Market Cap: US$495.8m

UroGen Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:URGN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Mar 24SellUS$168,600Mark SchoenbergIndividual12,000US$14.05
01 Feb 24SellUS$78,790Jason SmithIndividual4,993US$15.78
01 Feb 24SellUS$59,790Mark SchoenbergIndividual3,789US$15.78
28 Jul 23BuyUS$15,000,000Monograph Capital PartnersCompany1,572,327US$9.54

Insider Trading Volume

Insider Buying: URGN insiders have only sold shares in the past 3 months.


Ownership Breakdown

What is the ownership structure of URGN?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,6910.00496%
Hedge Funds1,726,8085.06%
Individual Insiders2,318,0536.79%
VC/PE Firms5,703,97516.7%
General Public6,602,09519.3%
Institutions17,769,46552.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 45.6%.


Top Shareholders

Top 25 shareholders own 69.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.04%
RA Capital Management, L.P.
3,083,430US$44.8m108%0.59%
7.68%
Great Point Partners, LLC
2,620,545US$38.1m0%5.24%
6.75%
Menora Mivtachim Pensions & Gemel Ltd.
2,303,031US$33.5m0%0.21%
5.06%
RTW Investments, LP
1,726,808US$25.1m101%0.43%
5.04%
BlackRock, Inc.
1,719,304US$25.0m43.6%no data
4.61%
Monograph Capital Partners
1,572,327US$22.8m0%no data
4.36%
Pontifax Venture Capital
1,487,669US$21.6m0%6.68%
4.01%
Moshe Arkin
1,369,315US$19.9m0%no data
3.52%
Credit Suisse Asset Management (Switzerland) Ltd.
1,200,000US$17.4m13.2%0.01%
2.55%
Harel Insurance Investments and Finances Services Ltd, Asset Management Arm
870,045US$12.6m-0.02%0.13%
1.9%
Migdal Mutual Funds Ltd.
648,302US$9.4m0%0.08%
1.54%
Silverarc Capital Management, LLC
525,404US$7.6m3.25%2.2%
1.45%
Wildcat Capital Management, LLC
495,606US$7.2m0%1.41%
1.44%
State Street Global Advisors, Inc.
490,831US$7.1m8.09%no data
1.3%
Morgan Stanley, Investment Banking and Brokerage Investments
444,798US$6.5m823%no data
1.25%
Millennium Management LLC
426,506US$6.2m54.7%0.01%
1.25%
Medical Strategy GmbH, Asset Management Arm
425,932US$6.2m0%0.36%
1.2%
Arie Belldegrun
408,693US$5.9m0%no data
0.96%
Elizabeth Barrett
326,941US$4.8m0%no data
0.94%
Opaleye Management Inc.
320,000US$4.6m0%1.12%
0.92%
Geode Capital Management, LLC
312,516US$4.5m42.6%no data
0.75%
Superstring Capital Management LP
255,430US$3.7m0%3.27%
0.73%
Laurion Capital Management LP
250,600US$3.6m-34.2%0.13%
0.69%
Northern Trust Global Investments
235,236US$3.4m32.6%no data
0.62%
Wells Fargo & Company, Securities and Brokerage Investments
212,000US$3.1m-0.28%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.